Serial 97672111

What this means for you

This application is over — abandoned 23 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

97672111

Mark type

Design / logo

Filed

10 Nov 2022

Published for opposition

26 Sept 2023

Abandoned

23 Dec 2024

Attorney of record

Monica Riva Talley

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection

Owner

• Galera Therapeutics, Inc., Malvern, PA, US
• Galera Therapeutics, Inc., Malvern, PA, US

Prosecution history

• 23 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 23 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
• 16 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 15 May 2024 — SOU EXTENSION 1 GRANTED
• 15 May 2024 — SOU EXTENSION 1 FILED
• 15 May 2024 — SOU TEAS EXTENSION RECEIVED
• 21 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 26 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 26 Sept 2023 — PUBLISHED FOR OPPOSITION
• 06 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 24 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 24 Aug 2023 — ASSIGNED TO EXAMINER
• 02 Dec 2022 — NOTICE OF DESIGN SEARCH CODE E-MAILED
• 01 Dec 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 14 Nov 2022 — NEW APPLICATION ENTERED